UBS O'Connor’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $595K | Sell |
13,771
-11,721
| -46% | -$506K | 0.03% | 239 |
|
|
2025
Q1 | $881K | Sell |
25,492
-35,626
| -58% | -$1.23M | 0.03% | 185 |
|
|
2024
Q4 | $1.68M | Buy |
61,118
+2,522
| +4% | +$69.2K | 0.04% | 173 |
|
|
2024
Q3 | $1.49M | Buy |
58,596
+22,096
| +61% | +$563K | 0.04% | 217 |
|
|
2024
Q2 | $925K | Buy |
+36,500
| New | +$925K | 0.03% | 302 |
|
|
2024
Q1 | – | Sell |
-14,318
| Closed | -$578K | – | 437 |
|
|
2023
Q4 | $578K | Sell |
14,318
-42,982
| -75% | -$1.74M | 0.02% | 326 |
|
|
2023
Q3 | $1.51M | Buy |
+57,300
| New | +$1.51M | 0.03% | 280 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 525 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 563 |
|